Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/2006
10/19/2006WO2006108473A1 Method for the determination of cellular transcriptional regulation by micro rnas
10/19/2006WO2006108423A2 Methods for production of oligonucleotides
10/19/2006WO2006108422A2 Methods for production of oligonucleotides
10/19/2006WO2006108276A1 A method of treating cancer using dichloroacetate
10/19/2006WO2006108229A1 Isolation of adult multipotential cells by tissue non-specific alkaline phosphatase
10/19/2006WO2006108225A1 Method of screening for compounds that modulate cell proliferation
10/19/2006WO2006096735A3 Enhancing a luminescent signal
10/19/2006WO2006085684A9 Method of diagnosing bladder cancer
10/19/2006WO2006084130A9 Ultra-sensitive detection systems using multidimension signals
10/19/2006WO2006082402A3 Biochemical reagents and their uses
10/19/2006WO2006081583A3 Methods and compositions for improving fidelity in a nucleic acid synthesis reaction
10/19/2006WO2006081426A3 Compositions and methods for terminating a sequencing reaction at a specific location in a target dna template
10/19/2006WO2006078861A9 Method, system and apparatus for a time stamped visual motion sensor
10/19/2006WO2006078648A3 Rhinovirus vaccines
10/19/2006WO2006071582A3 Methods, compositions, and kits for forming self-complementary polynucleotides
10/19/2006WO2006068170A9 Method for improvement of heat stability of glucose dehydrogenase
10/19/2006WO2006065349A3 Detection of microbe contamination on elastomeric articles
10/19/2006WO2006062389A3 Methods using mitochondrial nucleic acid for determining a health status of an individual
10/19/2006WO2006042223A3 Old-35 as an inflammatory agent
10/19/2006WO2006039676A3 Method of identifying inhibitors of viral multiplication eukaryotic cells
10/19/2006WO2006036388A3 Systems and methods for detecting and analyzing polymers
10/19/2006WO2006031843A3 Detection of cancer cells in body fluids
10/19/2006WO2006012134A3 Genetic diagnostic method for scd risk stratification
10/19/2006WO2006009814A3 Products and methods related to mono-methyl branched-chain fatty acids
10/19/2006WO2006008294A3 Diagnostic and therapeutic use of slim3 for neurodegenerative diseases
10/19/2006WO2006004597A3 Association of breast cancer dna methylation profiles with hormone receptor status and response to tamoxifen
10/19/2006WO2005123952A3 Particles embedded ina porous substrate for removing target analyte from a sample
10/19/2006WO2005123951A3 Methods of human leukocyte antigen typing by neighboring single nucleotide polymorphism haplotypes
10/19/2006WO2005117943A3 Biomarkers for monitoring inhibition of impdh pathway
10/19/2006WO2005115737A3 System and method for detecting and identifying an analyte
10/19/2006WO2005111622A8 Diagnostic assay for trypanosoma cruzi infection
10/19/2006WO2005081783A3 Method for determination and quantification of radiation or genotoxin exposure
10/19/2006WO2005080593A8 P53 wild-type as biomarker for the treatment with mtor inhibitors in combination with a cytotoxic agent
10/19/2006WO2005079342A3 Methods for coupling resistance alleles in tomato
10/19/2006WO2005016132A3 Diagnostics for sars virus
10/19/2006WO2004106491A8 Angiogenin-based hiv-1 therapies
10/19/2006WO2003031932A3 Methods and compositions for detecting colon cancers
10/19/2006WO2003027637A3 Assessment of neurons in the arcuate nucleus to screen for agents that modify feeding behavior
10/19/2006US20060236422 Methods of distinguishing ear shape and resistance against gibberella zeae and method of improving barley plant using the same
10/19/2006US20060236415 Neural crest cells specific promoters; isolated neural crest cells; and methods of isolating and of using same
10/19/2006US20060236410 Protein specific for cardiac and skeletal muscle
10/19/2006US20060235625 Methods and materials for canine breed identification
10/19/2006US20060235558 Method of scavenging intermediate formed by reaction of oxidoreductase with substrate
10/19/2006US20060235284 Glucose extraction patch and its manufacturing process
10/19/2006US20060235201 Enduring T cell response
10/19/2006US20060235023 Inhibitors of macrophage migration inhibitory factor and methods for indentifying the same
10/19/2006US20060234965 Novel full-length genomic rna of Japanese encephalitis virus, infectious jev cdna therefrom, and use thereof
10/19/2006US20060234940 Secondary binding site of dipeptidyl peptidase IV (DP IV)
10/19/2006US20060234937 Modulation of angiogenesis
10/19/2006US20060234926 Nucleic acid ligands and uses therefor
10/19/2006US20060234924 A kit for screening a compound or its salt that promotes or inhibits the activity of the proteins; drug screening for hyperlipemia, arteriosclerosis, genital, digestive, respiratory diseases, renal, pancreatic, central nerve, respiratory, inflammatory, rheumatoid diseases and diabetic neurosis
10/19/2006US20060234390 Process for determining target function and identifying drug leads
10/19/2006US20060234373 Treatment for diabetes
10/19/2006US20060234367 Yeast cells; ribonuclease barnase marker gene; libraries; drug resistance
10/19/2006US20060234344 Protein kinases
10/19/2006US20060234343 deletion of residues in the CR2 domain of the EGFR ectodomain gives rise to a truncated ectodomain with enhanced affinity for epidermal growth factors such as (EGF) and/or transforming growth factor-I (TGF- alpha ); psoriasis and tumor states
10/19/2006US20060234331 Method of selecting escherichia coli strain overexpressing foreign gene escherichia coli mutant thus selected and process for producing enzyme and compound using the same
10/19/2006US20060234330 Variable resistance sterilization process challenge device and method
10/19/2006US20060234329 Method for determining the antiradical defense potential and use thereof, in particular in veterinary and human preventive therapeutics
10/19/2006US20060234328 Anthrax lethal factor is a MAPK kinase protease
10/19/2006US20060234327 Methods for identifying enzyme inhibitors and protein kinases
10/19/2006US20060234326 Mass spectrometry methods for simultaneous detection of metabolic enzyme activity and metabolite levels
10/19/2006US20060234325 Hematological assay and kit
10/19/2006US20060234324 Calcium-binding photoprotein, coelenterazine and imidazole compound which removes NH-proton of pyrazine ring of imidazopyrazine
10/19/2006US20060234323 Luminescent ATP detection with extended linearity
10/19/2006US20060234313 Modulation of angiogenesis through targeting of arginyl transferase (ATE1)
10/19/2006US20060234310 Enriched antigen-specific T-cells and related therapeutic and prophylactic compositions and methods
10/19/2006US20060234309 Quality assays for antigen presenting cells
10/19/2006US20060234308 Method for determining the substrate specificity of an enzymatic activity and a device therefor
10/19/2006US20060234290 Novel genes and expression products therefrom
10/19/2006US20060234289 Sp110, a polypeptide component of the nuclear body
10/19/2006US20060234288 Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto
10/19/2006US20060234287 Breast cancer progression signatures
10/19/2006US20060234286 Human paris-1 antigen and nucleic acids: diagnostic and therapeutic uses
10/19/2006US20060234285 For treating or preventing inflammatory diseases, autoimmune diseases, graft versus host disease (GVHD), allergis, asthma, and/or hepatitis; drug screening
10/19/2006US20060234284 Methods of using molecular constructs for detection of biochemical reactions
10/19/2006US20060234283 reporter system reflecting the transport process that transports GPI-anchored proteins to the cell wall was constructed and compounds inhibiting this process were discovered; antifungal agents; inhibiting expression of cell wall glycoproteins and preventing pathogens from showing pathogenicity
10/19/2006US20060234282 Novel galanin receptor
10/19/2006US20060234281 Novel galanin receptor
10/19/2006US20060234280 Enyzmes having alpha amylase activity and methods of making and using them
10/19/2006US20060234279 Screening using polarization anisotropy in FRET emissions
10/19/2006US20060234278 Sequences used to identify if a female mammal comprises a mutation in the alpha-fetoprotein sequence(S) or a partial or total deletion of the alpha-fetoprotein sequence(S)
10/19/2006US20060234277 Method for selectively blocking hemoglobin RNA amplification
10/19/2006US20060234276 Methods of treatment of type 2 diabetes
10/19/2006US20060234275 Method for collecting purified cells
10/19/2006US20060234274 Methods of diagnosis
10/19/2006US20060234273 Id-1 and Id-2 genes and products as markers of epithelial cancer
10/19/2006US20060234272 Using gene panels to predict tissue sensitivity to ionizing radiation
10/19/2006US20060234271 Methods for the diagnosis and treatment of metastatic prostate tumors
10/19/2006US20060234270 Normalization methods for gene expression analysis
10/19/2006US20060234269 Laser Modification and Functionalization of Substrates
10/19/2006US20060234268 Linear amplification of rna
10/19/2006US20060234267 Genetic hybridization probes; high throughput assay; kits
10/19/2006US20060234266 Methods for detecting multiple species and subspecies of Neisseria
10/19/2006US20060234265 Microarrays having multi-functional, compartmentalized analysis areas and methods of use
10/19/2006US20060234264 Multiplex polynucleotide synthesis
10/19/2006US20060234263 Automatically preparing a sample, incubating the sample, preforming an analyte isolation procedure, ascertaining the presence of a target analyte, and analyzing the amount of a target analyte; performing multiple diagnostic assays simultaneously
10/19/2006US20060234262 Physiogenomic method for predicting clinical outcomes of treatments in patients
10/19/2006US20060234261 Colorimetric readout of hybridization chain reaction
10/19/2006US20060234260 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection